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Desmosomes are intercellular adhesive junctions that
exhibit cell- and differentiation-speci®c differences in
their molecular composition. In complex epithelia,
desmosomes contain multiple representatives of the
desmosomal cadherin family, which includes three
desmogleins and three desmocollins. Rules govern-
ing the assembly of desmosomal cadherin isoforms
into desmosomes of different cell types are
unknown. Here we compared the assembly proper-
ties of desmoglein 2 (Dsg2) and desmocollin 2
(Dsc2), which are widely expressed, with Dsg1 and
Dsc1, which are expressed in the differentiated layers
of complex epithelia, by introducing myc-tagged
forms into simple and squamous epithelial cells that
do not express Dsg1 or Dsc1. Dsc2.myc and
Dsg2.myc assembled ef®ciently into desmosomes in
every cell type in spite of signi®cant shifts in the stoi-
chiometric relationship between desmogleins and
desmocollins. In contrast, Dsc1a.myc, Dsc1b.myc,
and Dsg1.myc did not stably incorporate into
desmosomes in any line. Coexpression of Dsc1a.myc
or Dsc1b.myc and Dsg1.myc did not lead to their
colocalization and failed to enhance incorporation of
either cadherin into desmosomes. Dsg1.myc, but not
Dsc1a, Dsc1b, disrupted desmosome assembly in a
cell-type-speci®c manner, and disruption correlated
with the recruitment of Dsg1.myc, but not Dsc1a or
Dsc1b, into a Triton-insoluble pool. The
plakoglobin:E-cadherin ratio decreased in Dsg1-
expressing cells with disrupted desmosomes, but a
decrease was also observed in a Dsc1a line. Thus, a
modest reduction of plakoglobin associated with E-
cadherin is apparently not suf®cient to disrupt des-
mosome assembly. Our results demonstrate that des-
mosome assembly tolerates large shifts in cadherin
stoichiometry, but is sensitive to isoform-speci®c dif-
ferences exhibited by desmogleins and desmocollins.
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D
esmosomes are intercellular adhesive junctions that
anchor the intermediate ®lament (IF) cytoskeleton
to the plasma membrane, thus providing mechanical
strength to a tissue (Green and Gaudry, 2000).
Although desmosomes are abundant in epithelia,
particularly the epidermis, they can also be found in diverse cell
types such as cardiac muscle, pia and arachnoid meninges, and
follicular dendritic cells (Farquhar and Palade, 1963; Staehelin,
1974; Garrod, 1993). This diversity of tissue distribution is
mirrored by differences in desmosome composition in different
body sites. The transmembrane glycoproteins of desmosomes, the
desmosomal cadherins, are major contributors to this desmosomal
complexity (Jones and Green, 1991; Magee and Buxton, 1991;
Cowin and Burke, 1996; Gumbiner, 1996). These cadherins fall
into two subclasses known as desmogleins (Dsg) and desmocollins
(Dsc), the latter existing in two alternatively spliced forms, a and b,
differing in their intracellular domains (Magee and Buxton, 1991;
Buxton et al, 1993; Cowin, 1994; Koch and Franke, 1994). Each
desmosomal cadherin subclass comprises three separate isoforms
(Dsg1±3 and Dsc1±3), which are the products of distinct genes that
are expressed in a cell-type- and differentiation-speci®c manner
(Buxton et al, 1993; Koch and Franke, 1994; Garrod et al, 1996).
Dsg2 and Dsc2 are widely expressed and are found together in
desmosomes of the basal layer of strati®ed epithelia, simple
epithelia, and nonepithelial cells such as in the myocardium of
the heart and lymph node follicles, whereas Dsg3/Dsc3 and Dsg1/
Dsc1 are more restricted to complex epithelial tissues (Theis et al,
1993; Schafer et al, 1994; Nuber et al, 1995). Although considerable
overlap is exhibited in the distribution of these isoforms in strati®ed
tissues, their expression is clearly differentiation-dependent. For
instance, in epidermis, Dsg3 and Dsc3 are found predominantly in
the basal and suprabasal layers of strati®ed epithelia whereas Dsg1
and Dsc1 are found in the more differentiated layers (Nuber et al,
1995, 1996; North et al, 1996; Chidgey et al, 1997; King et al,
1997). A role for desmosomal cadherins in adhesion and tissue
integrity is supported by the experimental ablation and mutation of
Dsg, resulting in defects in the epidermis and its appendages in mice
(Allen et al, 1996; Koch et al, 1997), and by the existence of human
autoimmune and inherited blistering diseases that target the
desmosomal cadherins (Amagai, 1994; Amagai et al, 1994;
Stanley, 1995; Rickman et al, 1999). Both Dsg and Dsc are
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required for conferring adhesive properties on normally non-
adherent L929 cell ®broblasts, and it has been suggested that these
cadherins can interact in a heterophilic manner (Chitaev and
Troyanovsky, 1997; Marcozzi et al, 1998; Tselepis et al, 1998). The
precise requirements necessary for adhesion are not fully under-
stood, however (Kowalczyk et al, 1996), and it seems likely that
adhesion depends on parameters such as the stoichiometric
relationship between Dsc, Dsg, and plakoglobin. In addition, the
preferred binding partners in vivo are totally unknown.
The cytoplasmic tails of the desmosomal cadherins share certain
similarities, but also exhibit important differences. These domains
link the plasma membrane to the IF cytoskeleton through a
complex of proteins. This complex includes plakoglobin, which
binds directly to the ICS domain found in all Dsg and the a form of
Dsc, and desmoplakin, which binds to plakoglobin and anchors IF
to the desmosomal plaque (Kouklis et al, 1994; Bornslaeger et al,
1996; Kowalczyk et al, 1997; Smith and Fuchs, 1998). The
sequence differences exhibited by the desmosomal cadherin
cytoplasmic domains and possible distinct preferences for other
potential binding partners, such as the plakophilins (Kowalczyk et
al, 1999; Hatzfeld et al 2000), suggest a complexity of protein±
protein interactions that would further increase the diversity of
desmosome structure and function. It has been demonstrated that
multiple Dsc and Dsg isoforms can coexist in a single junction
(North et al, 1996). It remains to be determined, however, whether
one desmosomal cadherin can substitute for another in desmosome
assembly.
In this study, we directly compare the assembly behaviors of full-
length tagged forms of the ubiquitous desmosomal cadherins, Dsg2
and Dsc2, to Dsg1, Dsc1a, and Dsc1b by introducing them into
A431 cells, MDCK cells, and SCC9 cells, which all normally
express Dsg2 and Dsc2 but not Dsg1 or Dsc1. Our data
demonstrate that ectopic Dsg2 and Dsc2 ef®ciently assemble into
desmosomes in cells that endogenously express these isoforms even
though their expression leads to a signi®cant shift in the ratio of
total Dsg to Dsc. In contrast, Dsc1a, Dsc1b, and Dsg1 did not
incorporate ef®ciently into desmosomes in these same cell types
even when expressed at levels comparable to or lower than ectopic
Dsg2 and Dsc2. Furthermore, even modest levels of Dsg1.myc, but
not Dsc1a or Dsc1b, result in desmosome disruption and IF
detachment in A431 cells. Together these data demonstrate that
epithelial cells can tolerate wide ranges in levels of endogenous
desmosomal cadherins, whereas low levels of heterotypic cadherins
not only do not incorporate into desmosomes, but also can, in
certain cells, disrupt them.
MATERIALS AND METHODS
Generation of cDNA constructs For full-length c-myc epitope
tagged human Dsc1a and Dsc1b, cDNA clones were isolated from
lambda gt11 and lambda ZAPII libraries generated from normal human
keratinocytes (a gift from Dr. John Stanley) and clones were constructed
using an overlap extension strategy. Nucleotide numbers correspond to
those previously reported (Accession z34522) (Theis et al, 1993);
nucleotides 191±2676/2723±2921 are assigned to the full-length Dsc1a
and nucleotides 191±2713 to the Dsc1b coding sequence, respectively.
p489 (1±1206) was partially digested with EcoRV, digested to
completion with SmaI, and ligated to an internal EcoRV site and an
EcoRV site in the polylinker of p483 (669±2530) to generate p512 (1±
2530) comprising the 5¢ part of Dsc1. For c-myc tagged Dsc1b, a c-myc
tag was added to the 3¢ end of the cDNA by polymerase chain reaction
(PCR) using primers T7 and KI4, consisting of BamHI site, a stop
codon, c-myc epitope, and the C-terminal portion of Dsc1b (5¢-CGG
GAT CCT ACA AGT AAT ATT CAG AAA TGA GCT TTT GCT
CCA CAT TTT TAA TCA GAG TG-3¢) on p426 (2380±2893). The
resulting PCR product was subcloned into pBluescript-SK (Stratagene,
La Jolla, CA) at BamHI site to generate p846. To extend a fragment to
overlap with p512, PCR was carried out on a mixture of the MscI
fragment of p483 (1650±2502) and NspI fragment of p846 (containing
the downstream portion of Dsc1b after 2482) using primers KI9,
consisting of the internal Dsc1 sequence (5¢-GGA ACA TAG AAG
AAA AGG-3¢), and KI4. The resulting PCR product was digested with
NdeI and BamHI and ligated to p512 to obtain the full length of Dsc1b
with a myc tag (p853). p853 was digested with SalI and BamHI and
subcloned into the SalI/BamHI site of the b-actin expression vector
(p104). The resulting plasmid was named p855.
To generate a c-myc tagged Dsc1a, sequential PCR was used to excise
2677±2722 from Dsc1 sequences, followed by extension and addition of
a c-myc tag at the 3¢ end of Dsc1a. First, PCR was carried out on p426
with primers T7 and KI1, complement of 2724±2740 joined to 2663±
2677 (5¢-CCA CAC AAA TAC ACC TTT TCG CCA AGC CGA
GG-3¢), and primers KI2, nucleotides 2663±2677 joined to 2724±2740
(5¢-CCT CGG CTT GGC GAA AAG GTG TAT TTG TGT GG-3¢),
and KI5, containing a BamHI site, a stop codon, c-myc epitope, and the
C-terminal portion of Dsc1a (5¢-CGG GAT CCT ATT TCT TGA
TGC ATG TCT TTG CTA ATG TCC TAA ATT TGG GTT C-3¢).
The subsequent PCR on a mixture of these two products with primers
T7 and KI3 (5¢-CGG GAT CCT ACA AGT CCT CTT CAG AAA
TGA GCT TTT GCT CCA CTT TCT TGA TGC ATG TC-3¢) was
used to add the myc tag on the 3¢ end. The resulting PCR product was
subcloned into pBluescript-SK at BamHI to generate p861, which
encodes the 3¢ region of Dsc1a with myc tag. To extend the overlap
region with p512, PCR was used on a mixture of the MscI fragment of
p483 (1650±2502) and the NspI fragment of p861 (2482±2908) with
primers KI9 and KI5. PCR was performed on this PCR product with
primers KI9 and KI3. The resulting PCR product was digested with
NdeI and BamHI and ligated to p512 to generate the full length of
Dsc1a with a myc tag (p853). The c-myc tagged Dsc1a was ligated into
the SalI/BamHI site of the b-actin expression vector (p104), and termed
p854. The Dsc1a.myc and Dsc1b.myc clones were sequenced and
compared with the published sequence, a clone obtained from Dr.
Takashi Hashimoto (Hashimoto et al, 1997), and other available data-
bases. The sequence of the Dsc1a and Dsc1b clones used in this work
differed by two and one different amino acids, respectively, from
Accession z34522, but these were both present in sequences in another
available clone (Accession X72925) (King et al, 1993) and are thus likely
to represent polymorphisms.
Full-length c-myc epitope tagged human Dsc2a was removed from
p390 (Kowalczyk et al, 1994) using SalI and HindIII sites and then
ligated to a puri®ed, SalI/HindIII digested b-actin expression vector; the
resulting plasmid used for these studies was named p476.
A cDNA construct encoding human Dsg2 in pBluescript R3 BptII
SR± was a gift from Drs W. Franke and S. Schafer. We termed this
plasmid p594. To generate a C-terminal myc epitope tag on Dsg2, a
PCR using p594 as template was performed. A primer consisting of the
internal Dsg2 sequence termed SN8-(5¢ GCC AAT GCA GAG AAA
GTA AC 3¢) and a primer consisting of three restriction sites, AatII,
BamHI, XhoI, a stop codon, c-myc epitope, and the C-terminal portion
of Dsg2 termed SN9-(5¢ GTG ACG TCT GAT CCC TCG AGC TAC
AAG TCC TCT TCA GAA ATG AGC TTT TGC TCC ACG GAG
TAA GAA TGC TG 3¢) were used to generate a C-terminally c-myc
epitope tagged Dsg2 cDNA fragment. This fragment was puri®ed and
digested with AatII and BglII and then ligated back into AatII/BglII
digested and puri®ed p594 containing the remaining Dsg2 N-terminal
region. The resulting full-length C-terminally c-myc epitope tagged
human Dsg2 in pBluescript R3 BptII SR± was termed p685. Myc-
tagged Dsg2 was removed from p685 using BamHI and was ligated to
BamHI digested b-actin (p104) to generate the ®nal expression vector,
which was termed p726.
c-myc epitope tagged Dsg1 cDNA and c-myc epitope tagged
plakoglobin cDNA were described previously (Kowalczyk et al, 1994;
Norvell and Green, 1998).
Cell culture and generation of stable lines Parental MDCK cells (a
gift from Dr. Peter Kopp) were cultured in Dulbecco's modi®ed Eagle's
medium (DMEM) (Mediatech, Hernden, VA) containing 10% fetal
bovine serum (FBS), 100 units penicillin per ml, and 100 mg per ml
streptomycin. The oral squamous cell carcinoma line SCC9 was obtained
from Dr. Jim Rheinwald. Parental SCC9 cells were cultured in DMEM/
F-12 (Life Technologies, Rockville, MD) containing 10% FBS, 100 units
penicillin per ml, and 100 mg per ml streptomycin. To obtain mass-
selected cells, cells were cotransfected with calcium phosphate
precipitates containing each myc-tagged desmosomal cadherin vector and
selected under 400 mg per ml of G418 sulfate (Mediatech) for SCC9
cells and 500 mg per ml of G418 for MDCK cells. For Dsg1.myc, the
plasmid was cotransfected with neomycin-resistant expression vector.
A431 epithelial cells were a gift from Dr. M. Wheelock, University of
Toledo. Parental A431 cells were cultured in DMEM containing 10%
FBS, 100 units per ml penicillin, and 100 mg per ml streptomycin. Stable
cell lines expressing myc-tagged desmosomal cadherin or control cell
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lines expressing neomycin resistance (Neo) were generated as described
previously (Norvell and Green, 1998). Mass-selected cells expressing
both Dsg1.myc and Dsc1-myc were generated by re-transfection of line
18 expressing Dsg1.myc with Dsc1a-myc (p854) or Dsc1b-myc (p855)
plasmid, and they were selected using 500 mg per ml G418 sulfate with 1
mg per ml puromycin (Sigma Chemical, St. Louis, MO) to maintain
Dsg1.myc expression. Stable cell lines expressing full-length Dsg1.myc
and plakoglobin (Dsg1.myc + Pg) were generated by re-transfection of
line 18 expressing Dsg1.myc with Pg.myc (p330), and were selected
using 1 mg per ml puromycin (Sigma Chemical), to maintain Dsg1.myc
expression, and 700 mg per ml G418 sulfate (Mediatech), to select for
plakoglobin expression. Control Dsg1 + Neo lines were generated by
re-transfection of Dsg1.myc (18) with the b-actin promoter driving the
neomycin resistance marker.
Antibodies The following mouse monoclonal antibodies were used in
this study: DP2.15, against the desmoplakin I/II rod domains (Cowin et
al, 1985); KSB17.2, against keratin 18 (Sigma Chemical); anticytokeratin
peptide 8 (Sigma Chemical); 6D8, against Dsg2 (Wahl et al, 1996); 7G6,
against Dsc2 (Wahl et al, 1996); HECD-1, against E-cadherin; U100,
against Dsc1 (Research Diagnostics, Flanders, NJ). The following rabbit
polyclonal antibodies were used: 795, against E-cadherin (a gift from Drs
R. Marsh and R. Brackenbury); 2026, against the c-myc epitope tag,
referred to here as poly myc (a gift from Dr. J. Stanley); NW161, against
desmoplakin (Bornslaeger et al, 1996). Also, 982, a human pemphigus
autoantibody against Dsg1 (Kowalczyk et al, 1995), and 1407, a chicken
antiplakoglobin antibody, were used (Gaudry et al, in press).
Immuno¯uorescence Cells were plated on glass coverslips for 2 d
and were then rinsed in complete phosphate-buffered saline (PBS) and
®xed in methanol for 2 min at ±20°C. The following antibodies were
used: 2026 poly myc (1:700), 1407 (1:100), KSB17.2 (1:200), 982
(1:100), NW161 (1:100), DP2.15 (1:200). Alexa Fluor conjugated
secondary antibodies (Molecular Probes, Eugene, OR) or the ¯uorescein
or rhodamine conjugated secondary antibodies (Kirkegaard and Perry
Laboratories, Gaithersburg, MD) were used. Marina Blue antirabbit IgG
conjugate (Molecular Probes) was used for triple labeling. Processed
coverslips were mounted in Vinol (Air Products and Chemicals,
Allentown, PA) and examined with a Leitz DMR microscope.
Photographs were taken on a Leitz orthomat E camera using T-MAX
100 or Ektachrome ®lm (Kodak, Rochester, NY), or images were
captured using a Hamamatsu Orca digital camera and Improvision
Openlab software.
Cell fractionation and immunoprecipitations Cells were
fractionated into Triton-soluble and Triton-insoluble pools using
coimmunoprecipitation buffer [1% Triton X-100, 145 mM NaCl, 10 mM
Tris-HCl, pH 7.4, 5 mM ethylenediamine tetraacetic acid, 2 mM
ethyleneglycol-bis(b-aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid,
1 mM phenylmethylsulfonyl ¯uoride] as described previously (Norvell
and Green, 1998). For immunoprecipitations, 100 mm culture dishes of
con¯uent cells were washed in complete PBS, extracted in cold
immunoprecipitation buffer, and processed as described previously
(Norvell and Green, 1998). Some modi®cations to the procedure were
made in that 40 ml of Gamma Bind Plus Sepharose beads (Pharmacia,
Uppsala, Sweden) were used and samples were washed four times instead
of ®ve. The immunoprecipitates were then analyzed by sodium dodeyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotted as described below. One microliter of 795 anti-E-
cadherin antibody was used for each sample.
Immunoblots Cells were lyzed in SDS/urea buffer (1% SDS, 8 M
urea, 10 mM Tris-HCl, pH 7.5), and the concentration of each sample
was estimated by an Amido Black protein assay as described by Shef®eld
et al (1987). Equal loading on gels was con®rmed by immunoblot with
anticytokeratin peptide 8. Antibodies were used at the following
dilutions for immunoblots: poly myc, 1:4000; anticytokeratin peptide 8,
1:1000; 7G6 ascites, 1:1000; 6D8 ascites, 1:1000; 1407, 1:5000; and
NW161, 1:5000; HECD-1, 1:50. The appropriate peroxidase conjugated
secondary antibodies (Kirkegaard and Perry Laboratories) were used. To
estimate the levels of endogenous and ectopic proteins, densitometric
analysis was performed using the Bio-Rad Model GS-670 Imaging
Densitometer and the Molecular Analyst image analysis software.
RESULTS
Dsc2a.myc and Dsg2.myc, but not Dsc1a.myc and
Dsg1.myc, assemble ef®ciently into desmosomes in
MDCK and SCC9 cells To analyze potential differences in
assembly properties exhibited by desmosomal cadherin isoforms,
myc-tagged versions of the widely expressed desmosomal cadherins
Dsc2a and Dsg2 (Fig 1), and differentiation-speci®c desmosomal
cadherins Dsc1a, Dsc1b, and Dsg1 (Fig 1), were introduced into
the simple epithelial MDCK line and the oral squamous cell
carcinoma line SCC9. MDCK cells endogenously express Dsg2
and Dsc2 protein, along with minor amounts of Dsg3 and Dsc3,
but not Dsc1 and Dsg1 (Vilela et al, 1995; Roberts et al, 1998).
SCC9 cells express Dsg2, Dsc2, and lesser amounts of Dsg3 protein
(data not shown). Dsg1 was not detected in SCC9 cells under any
circumstances, consistent with our previous observations (Denning
et al, 1998). Following transfection of the myc-tagged constructs,
MDCK and SCC9 cells ectopically expressing myc-tagged
desmosomal cadherins were mass selected; immuno¯uorescence
showed that 5%±20% of cells expressed ectopic proteins.
Double- and triple-label immuno¯uorescence was carried out to
examine the relative distributions of ectopic cadherin, endogenous
desmosomes, and keratin IF. As the distribution of ectopic proteins
was similar for both cell lines, only data for MDCK are presented
here. Dsc2a.myc and Dsg2.myc were organized in a punctate
pattern, colocalizing with IF attachment sites at cell±cell borders
(Fig 2d±f, j±l). Both cadherins also colocalized with the desmo-
somal plaque protein, desmoplakin (Fig 3d±f, j±l), suggesting the
ectopic proteins were incorporated into desmosomes. In contrast,
Dsg1.myc and Dsc1a.myc did not colocalize with endogenous
desmosomes (Figs 2a±c, g±i; 3a±c, g±i). A small proportion of
Dsc1a localized at borders, but this occurred in the background of
diffuse and vesicular staining (Fig 3a±c). Dsg1.myc exhibited a
diffuse rather than punctate pattern on the plasma membrane.
These data suggested that, in contrast to Dsc2a and Dsg2, Dsc1a
and Dsg1 are unable to ef®ciently accumulate in existing
desmosomes in these simple epithelial or squamous cell lines.
Dsc2a.myc and Dsg2.myc, but not Dsc1a.myc, Dsc1b.myc,
or Dsg1.myc, assemble ef®ciently into desmosomes, and
Dsg1.myc, but not Dsc1a.myc, Dsc1b.myc, disrupts
desmosomes in A431 cells The assembly properties of
desmosomal cadherins were also analyzed in stable A431 cell lines
expressing Dsc1a.myc, Dsc1b.myc, Dsc2a.myc, Dsg2.myc and
compared with the Dsg1.myc 18 line reported in a previous study
(Norvell and Green, 1998). The A431 parental cells used here
expressed Dsg2, Dsc2, and some Dsc3. Dsg3 was detected only
upon very long exposures of immunoblots, and neither Dsg1 nor
Dsc1 were detected in A431 cells (data not shown). Cell lines
expressing varying levels of ectopic desmosomal cadherins were
selected for further study by immunoblot analysis using an antimyc
antibody (Fig 4). Both the Dsc1- and Dsg1-expressing lines
expressed lower levels of ectopic cadherin than did the Dsc2 and
Dsg2 lines. As expected, the total levels of Dsg2 in Dsg2.myc lines
Figure 1. Desmosomal cadherin constructs. cDNA constructs
encoding full-length Dsc1a and Dsc1b (Dsc1a.myc, Dsc1b.myc), full-
length Dsc2a (Dsc2a.myc), full-length Dsg1 (Dsg1.myc), and full-length
Dsg2 (Dsg2.myc) are shown. All of the constructs are c-myc epitope
tagged at the C-terminus. The schematic indicates speci®c domains
present in each desmosomal cadherin: EC1±EC4, four extracellular
cadherin-typical repeats; EA, extracellular anchor domain; M,
transmembrane domain; IA, intracellular anchor domain; ICS,
intracellular cadherin-speci®c domain; L, proline-rich linker domain;
RUD, repeating unit domain; DTD, Dsg-speci®c terminal domain.
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and total levels of Dsc2 in Dsc2a.myc lines increased (Fig 4). In
addition, decreases in the levels of endogenous Dsc2 were seen in
cell lines expressing ectopic protein, and as previously reported
averaged 3-fold in Dsg1.myc (18) cells (Fig 4).
As was observed in the case of MDCK and SCC9 cells, both
Dsg2.myc and Dsc2a.myc colocalized with desmoplakin in a
typical, punctate desmosome pattern at cell±cell interfaces of A431
cells (Fig 5e, f, i, j). The endogenous keratin tono®laments
appeared unperturbed, terminating normally at desmosomal plaques
where they colocalized with ectopic Dsg2 and Dsc2a. In contrast,
Dsc1a.myc, Dsc1b.myc, and Dsg1.myc were unable to ef®ciently
assemble into desmosomes (Fig 5a±d, g, h). In methanol-®xed
cells, Dsc1a.myc and Dsc1b.myc both exhibited a vesicular
cytoplasmic pattern and did not localize with desmoplakin at
cell±cell borders (Fig 5a±d). Live cell staining revealed that some
Dsc1 was present on the cell surface where it was organized
diffusely in a nondesmosomal pattern, consistent with previous
studies of transiently transfected COS cells subjected to live cell
staining (Hashimoto et al, 1997) (not shown). Cells expressing
Dsc1a or Dsc1b appeared to have a normal distribution of
endogenous desmosomal components and the keratin pattern was
largely unperturbed (Fig 5b, d).
As previously described, ectopic Dsg1.myc localized diffusely at
the cell surface (Fig 5g, h) (Norvell and Green, 1998).
Desmoplakin was disorganized and keratin tono®laments extending
to the cell periphery were perturbed (Fig 5h). In contrast,
disruption of desmosomes by Dsg1.myc or Dsc1.myc was not
detected among populations of mass-selected SCC9 or MDCK
cells (Figs 2, 3). Similar results were obtained using a FLAG-tagged
Dsg1 construct in A431 cells (data not shown).
Dsg1.myc, but not Dsc1a.myc or Dsc1b.myc, incorporates
into a Triton-insoluble pool To examine possible biochemical
differences that could account for the observed differences in
assembly behavior among the desmosomal cadherin isoforms, cells
were fractionated into Triton-soluble and Triton-insoluble pools.
Dsg2 and Dsc2 partitioned between these pools as would be
expected based on the distribution of endogenous desmosomal
cadherins in neomycin-resistant control A431 cell lines (Fig 6).
Consistent with our previous observations, Dsg1 also partitioned
into both pools, with the majority found in the Triton-insoluble
pool. Both Dsc1a and Dsc1b remained largely Triton-soluble,
however, consistent with the immuno¯uorescence data suggesting
that Dsc1a.myc and Dsc1b.myc localized in cytoplasmic vesicular
structures. When normalized for protein loading, the distribution of
endogenous desmosomal cadherins, Dsg2 and Dsc2, plakoglobin,
and desmoplakin was not consistently altered.
Coexpression of Dsg1.myc and Dsc1.myc did not lead to
their colocalization or assembly into desmosomes in A431
cells Dsg1 and Dsc1 are similarly distributed in the upper layers
Figure 2. Dsc2a.myc and Dsg2.myc, but not
Dsc1a or Dsg1.myc, exhibit a punctate,
desmosomal pattern in MDCK cells but none
of these cadherins disrupts keratin IF. Mass-
selected population of MDCK cells expressing
Dsc1a.myc (a±c), Dsc2a.myc (d±f), Dsg1.myc (g±i),
and Dsg2.myc (j±l) were subjected to triple-label
immuno¯uorescence. The ectopic proteins were
detected by poly myc antibody (a, d, j) for
Dsc1a.myc, Dsc2a.myc, and Dsg2.myc, and an
antibody against Dsg1 for Dsg1.myc (g). The
pattern of ectopic proteins was compared with the
distribution of endogenous plakoglobin (b, e, h, k)
and keratin 18 (c, f, i, l). Note that Dsc2a.myc and
Dsg2.myc are localized in a punctate, desmosome
pattern on cell±cell borders, whereas most
Dsc1a.myc are in cytoplasmic vesicular structures
and Dsg1.myc is distributed diffusely on the cells.
The keratin IF pattern is not disrupted in any
case. For clarity, IF are represented here in red
and plakoglobin is represented in blue. Scale bars:
10 mm.
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of epidermis. Furthermore, it has been reported that Dsc and Dsg
associate in a heterophilic manner in human ®brosarcoma cells
stably expressing Dsc1a (Chitaev and Troyanovsky, 1997), and
coexpression of Dsc and Dsg with plakoglobin confers adhesive
properties on normally nonadherent mouse L cell ®broblasts
(Marcozzi et al, 1998; Tselepis et al, 1998). Therefore, we sought to
test whether coexpression of Dsg1 and Dsc1 is required for their
incorporation into desmosomes. The Dsg1.myc 18 line was re-
transfected with a plasmid encoding Dsc1a.myc or Dsc1b.myc, and
cells expressing Dsg1.myc and Dsc1a.myc, or Dsg1.myc and
Dsc1b.myc, were mass selected in G418-containing medium.
Immuno¯uorescence analysis showed that the distributions of Dsc1
and Dsg1 were not detectably altered by virtue of their presence in
the same cell (Fig 7a, b, d, e), and the localization of endogenous
desmoplakin remained abnormal (compare Fig 7c, f, i with Fig 7j).
Thus, coexpression of these cadherins is not suf®cient to ensure
their correct assembly into desmosomes.
Possible role of plakoglobin:E-cadherin complexes in
desmosome assembly We previously reported that 2±3-fold
less plakoglobin associates with E-cadherin in A431 cells with
disrupted desmosomes expressing an E-cadherin±Dsg1 chimera
(Norvell and Green, 1998). As plakoglobin:E-cadherin complexes
have been hypothesized to be critical intermediates in the
downstream assembly of desmosomes (Lewis et al, 1997), we
suggested that the Dsg1 cytoplasmic domain sequestered
plakoglobin from E-cadherin, thus disrupting desmosomes. To
examine this idea further, we generated cell lines in which the
Dsg1.myc line 18 was re-transfected with a C-terminally myc
epitope tagged, full-length plakoglobin cDNA. In parallel, control
cell lines that expressed Dsg1.myc and the Neo resistance marker
(FL Dsg1.myc + Neo) were established. We then (i) measured the
plakoglobin:E-cadherin ratio in Dsg1.myc, Dsg1.myc + Pg.myc,
and Dsg1.myc + Neo cell lines and (ii) determined whether
desmosomes recovered in Dsg1.myc + Pg.myc cell lines.
Six positive Dsg1.myc + Pg.myc cell lines (three of which are
shown in Fig 8) and two control Dsg1.myc + Neo cell lines were
selected for study. In Dsg1.myc + Pg cell lines, approximately 2±6-
fold more plakoglobin associated with E-cadherin compared with
controls. Cells expressing ectopic Dsg2.myc or Dsc2.myc did not
exhibit altered plakoglobin:E-cadherin ratios, correlating with their
inability to disrupt desmosome assembly (Fig 8). The Dsc1a L1 line
exhibited a decreased plakoglobin:E-cadherin ratio, however, in
spite of the lack of desmosome disruption in this line (Fig 8).
The Dsg1.myc + Pg.myc lines were then analyzed for desmo-
some rescue. Immunoblot analysis showed that each
Dsg1.myc + Pg line expressed at least as much Dsg1.myc as the
parental line; Dsg1.myc (not shown) and the Dsg1.myc + Pg lines
expressed similar levels of Pg.myc with slightly variable levels of
Dsg1.myc. Desmosomes were recovered in four of six
Figure 3. Dsc2a.myc and Dsg2.myc, but not
Dsc1a or Dsg1.myc, incorporate ef®ciently
into endogenous desmosomes in MDCK
cells. Double-label immuno¯uorescence was
carried out for mass-selected MDCK cells
expressing Dsc1a.myc, Dsc2a.myc, Dsg1.myc, and
Dsg2.myc. The ectopic proteins were detected by
poly myc antibody for Dsc1a.myc (a), Dsc2a.myc
(d), and Dsg2.myc (j), and an antibody against
Dsg1 for Dsg1.myc (g). An antibody against
desmoplakin was used as a marker for desmosomes
(b, e, h, k). Dual color overlays are shown on the
right (c, f, i, l). Note that Dsg2.myc and
Dsc2a.myc colocalize with desmoplakin (d±f; j±l),
whereas Dsc1a.myc (a±c) and Dsg1.myc (g±i)
appear as cytoplasmic vesicular structures with
occasional cell±cell border staining, or as diffuse
on the plasma membrane, respectively. Scale bars:
10 mm.
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Dsg1.myc + Pg.myc lines analyzed. One line exhibited partial
recovery of desmosomes and another did not exhibit recovery. This
trend toward desmosome recovery suggests that plakoglobin
probably plays a role in disruption by Dsg1 but is not suf®cient
for rescue of the disrupted phenotype.
DISCUSSION
The desmosomal cadherins exhibit considerable complexity within
epithelial tissues and within individual desmosomes (Arnemann et
al, 1993; Schafer et al, 1994; Nuber et al, 1995, 1996; North et al,
1996; Chidgey et al, 1997; King et al, 1997). Although the
implications of this complexity for desmosome assembly and
function are unknown, one recent study showed that forced
expression of Dsg3 in the super®cial epidermal layers of transgenic
mice can at least in part compensate for compromised Dsg1-
mediated adhesion, suggesting that at least some functions are
overlapping (Wu et al, 2000). This study did not address whether
Dsg are interchangeable in desmosome assembly, and it is still
largely unclear whether desmosomal cadherins can substitute for
each other functionally in every case.
The results presented here clearly demonstrate that desmosomal
cadherins are not interchangeable. We directly compared the
assembly behavior of the more widely expressed Dsg2 and Dsc2
with the differentiation-speci®c isoforms Dsg1 and Dsc1 by
examining the assembly properties of ectopically expressed myc-
tagged cadherins in different cell lines. Previous studies of out-of-
context assembly behavior of desmosomal cadherins were limited
to A431 cells; therefore, we extended the analysis to SCC9, a
transformed human keratinocyte line with a slightly different
expression pro®le than A431s, and MDCK, a nontransformed,
polarized simple epithelial cell line.
Ef®cient assembly of ectopic cadherins into desmosomes is
more dependent on isoform identity than expression
level In a previous study, we demonstrated that full-length
Dsg1, when expressed at even moderate levels in cells that normally
do not express this isoform, fails to incorporate normally into
desmosomes and interferes with junction assembly and IF
organization (Norvell and Green, 1998). Here we sought to
distinguish between isoform-speci®c effects on desmosome
structure and assembly, and dominant negative effects due to
over-expression of a desmosomal cadherin. Our results suggest that
Figure 4. Immunoblot analysis of relative levels of ectopic and
endogenous desmosomal cadherins in A431 stable cell lines. Cell
lysates of A431 cells stably expressing myc-tagged desmosomal cadherins
were separated by 7.5% SDS-PAGE and subjected to immunoblot with
antibodies against c-myc epitope tag (poly myc), Dsc2 speci®c antibody
(7G6), and Dsg2 speci®c antibody (6D8). The loading volumes of lysates
were normalized by measurement of protein volume using the Amido
Black method and immunoblot with antibodies against keratin 8 as
described in Materials and Methods. It should be noted that we recently
determined that the myc tags on Dsg1 and Dsg2 are recognized
differently on immunoblots (Bannon et al, in press and unpublished
observations). Taking this discrepancy into account, it was calculated that
Dsg2.myc-B3 and Dsg2.myc-D1 lines express at least 3-fold more myc-
tagged protein than the Dsg1 18 line, respectively.
Figure 5. Dsc2a.myc and Dsg2.myc, but not Dsc1a, Dsc1b.myc,
or Dsg1.myc, incorporate ef®ciently into endogenous A431 cell
desmosomes, and Dsg1 disrupts junctions. Double-label
immuno¯uorescence was performed on A431 stable cell lines expressing
Dsc1a.myc (L1 line) (a, b), Dsc1b.myc (K4) (c, d), Dsc2.myc (E2) (e, f),
Dsg1.myc (18) (g, h), Dsg2.myc (B3) (i, j). Myc-tagged ectopic
desmosomal cadherin and endogenous desmoplakin were visualized by
polyclonal myc antibody and antidesmoplakin (DP2.15), respectively (a,
c, e, i). In the case of Dsg1.myc, antibody against Dsg1 (982) and DP2.15
were used (g). In addition, double staining with poly myc and antikeratin
18 (KSB17.2) was carried out to detect ectopic proteins and keratin IF,
respectively (b, d, f, j). In the case of Dsg1.myc, anti-Dsg1 and
antikeratin 18 antibodies were used (h). Scale bar: 10 mm.
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isoform type, not expression level, is most important for
determining the fate of a particular desmosomal cadherin during
its traf®cking and assembly into desmosomes. This idea is supported
by the observation that Dsg2.myc and Dsc2.myc incorporated
ef®ciently into desmosomes of all cell types tested, regardless of
their level of expression. This was the case even when the ratio of
total Dsc2 to Dsg2 shifted dramatically from that normally existing
in the cell. Thus, alterations in stoichiometry are well tolerated
when a cadherin is introduced into a cell type that normally
expresses that cadherin. In contrast, Dsg1.myc did not ef®ciently
colocalize with endogenous desmosomes in the majority of cells
within a population, in any cell type tested. This was in spite of the
fact that Dsg1.myc was expressed at signi®cantly lower levels than
Dsg2.myc. Also, neither the a nor b forms of Dsc1 incorporated
ef®ciently, although within mass-selected populations of MDCK
and SCC9 lines a small proportion of cells exhibited some punctate
staining at cell borders.
Interestingly, the localization patterns of Dsg1 and Dsc1a, Dsc1b
were dissimilar in all of the lines. In the case of Dsc1, the presence
of what appeared to be cytoplasmic vesicles in all cell types
suggested that its traf®cking to, or stability at, the plasma membrane
was compromised. This could indicate a requirement for additional
binding partners in facilitating the stable and ef®cient incorporation
of Dsc1 into desmosomes. In addition, the failure of Dsg1 and
Dsc1a or Dsc1b to colocalize with each other in cells expressing
both ectopic proteins suggests that their possible cooperation in
adhesion or desmosome assembly may require additional binding
partners. Although the identity of such binding partners is
unknown, candidates for such a role might be members of the
emerging plakophilin family of arm proteins.
Dsg1, but not Dsc1, disrupted desmosomes in a cell-type-
dependent manner Dsg1 not only does not incorporate
ef®ciently into desmosomes comprising primarily Dsg2 and Dsc2,
it also disrupted desmosomes and IF attachment in A431 cells
(Norvell and Green, 1998). In contrast, Dsc1a or Dsc1b did not
appear to disrupt desmosomes in this cell type. Previously, it was
reported that an untagged connexin±Dsg1 chimera failed to recruit
desmoplakin and IF to cell±cell borders and disrupted endogenous
desmosomes in A431 cells (Troyanovsky et al, 1993), and an E-
cadherin±Dsg1 chimera exhibited similar properties (Norvell and
Green, 1998), consistent with results for full-length Dsg1. A
connexin chimera with a Dsc1 intracellular domain recruited,
rather than disrupted, desmoplakin and associated IF, however.
Nevertheless this chimera had some negative impact on desmosome
assembly in A431 cells, as endogenous Dsg2 was not recruited into
structures containing connexin/Dsc1, plakoglobin, and desmo-
plakin, and Dsg2 remaining at the cell surface was distributed
somewhat abnormally (Troyanovsky et al, 1993). Here we show
that full-length Dsc1 does not interfere with the recruitment and
assembly of endogenous proteins in A431 cells. This observation is
consistent with a recent report showing that forced expression of
Dsc1 in the basal layer of mouse epidermis has no apparent negative
impact on keratinocyte adhesion (Henkler et al, 2001).
Our observations suggest that Dsg1-mediated disruption is cell-
type dependent. Neither Dsg1 nor Dsc1 appeared to disrupt
desmosomes in MDCK or SCC9 cells. This is in spite of the fact
that Dsg1 displays a similar diffuse distribution in all cell types
tested, none of which express Dsg1 endogenously. It is possible that
A431 cells may be more susceptible to the disruptive effect of Dsg1
due to differences in expression of certain protein partners, or
perhaps post-translational modi®cations such as phosphorylation.
Recently it was reported that an extracellularly truncated Dsg1
molecule did disrupt desmosomes in stable MDCK cell lines
(Serpente et al, 2000). The underlying reasons for the difference in
the effects exerted by full-length and truncated versions of Dsg1 in
MDCK cells are unclear. It seems unlikely that expression levels of
full-length Dsg1.myc were not high enough in the mass-selected
populations to lead to disruption, as immuno¯uorescence analysis
using the same Dsg1 antibody showed that a proportion of the
mass-selected cells expressed higher Dsg1 levels than the stable
A431 cell lines. It seems more likely that the differing results are
due to differences in behavior exhibited by the truncated versus full-
length versions of Dsg1.
Desmosome disruption by Dsg1 correlates with its ability to
incorporate into the Triton-insoluble pool, but not with
plakoglobin:E-cadherin ratios, which are depressed in both
Dsg1- and Dsc1-expressing lines The ability of desmosomal
cadherins to assemble into desmosomes is likely to be dependent on
proper interactions with partners that bind to both the extracellular
and cytoplasmic domains. In the case of desmosomal cadherins the
role of the extracellular domains may be particularly important as
these cadherins are thought to interact heterophilically, and the
absence of a preferred extracellular ligand could theoretically be
disruptive. It seems somewhat unlikely that the lack of an
extracellular ligand in A431 cells is responsible for the disruptive
effect of Dsg1 in this cell type, as MDCK cells are equally unlikely
to express Dsg1¢s normal adhesion partner. Nevertheless, in order
to test the idea that Dsg1¢s likely binding partner, Dsc1, might
engage Dsg1, possibly ameliorating its disruptive effects, these
proteins were coexpressed in A431 cells. In cells expressing Dsg1
and either Dsc1a or Dsc1b, however, no obvious colocalization was
observed. Cadherin did not accumulate in endogenous
desmosomes nor were there reproducible effects on desmosome
structure, suggesting that additional cell-type-speci®c partners are
required in differentiating cells.
Disruption of cell±cell junctions by cadherin cytoplasmic
domains has been observed in a number of cell systems (Kintner,
1992; Fujimori and Takeichi, 1993; Amagai et al, 1995; Hermiston
and Gordon, 1995a; 1995b; Zhu and Watt, 1996; Nieman et al,
1999; Troxell et al, 1999; Hanakawa et al, 2000; Serpente et al,
2000). Investigators have proposed that disruption may be due to
sequestration of binding partners necessary for junction assembly
such as b-catenin or plakoglobin, or possibly to replacement of
functional cadherins at sites of cytoskeletal-membrane attachment
with a nonfunctional cadherin tail. The ability of Dsg1, but not
Dsc1, to cause desmosome disruption correlated with differences in
Figure 6. Dsg1.myc, but not Dsc1a.myc or Dsc1b.myc,
partitions into the Triton-insoluble pool in A431 cell lines. Cells
were prepared with 1% Triton-containing buffers and fractioned into
Triton-soluble (S) and Triton-insoluble (I) pools. Subsequently, samples
were separated by 7.5% SDS-PAGE and immunoblot analysis was
performed with antibodies against c-myc epitope tag (poly myc), Dsc2
speci®c antibody (7G6), Dsg2 speci®c antibody (6D8), antiplakoglobin
(1407), and antidesmoplakin (NW161). Note that Dsg2, Dsc2, and Dsg1
all partitioned between Triton-soluble and Triton-insoluble pools,
whereas Dsc1a and Dsc1b remained largely in the soluble pool. When
normalized for protein loading, major changes in endogenous
components were not observed.
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the ability of these cadherins to partition into the Triton-insoluble
pool. Dsg1¢s ability to partition into the Triton-insoluble pool
suggests that its cytoplasmic domain may interact with other
junctional or cytoskeletal components, possibly sequestering build-
ing blocks required for normal desmosome assembly. That Dsc1
does not partition into this pool may mean that it cannot partner
with other junction intermediates, thus resulting in both inef®cient
incorporation into junctions and failure to disrupt existing
junctions.
Extracellularly deleted Dsg1 does not incorporate into the
Triton-insoluble pool but nevertheless disrupts junctions (Serpente
et al, 2000). The possibility was raised that this disruptive effect
could be due to sequestration of plakoglobin. Indeed, based on
evidence suggesting the critical role of E-cadherin:plakoglobin
complexes in initiating desmosome assembly (Lewis et al, 1997), we
previously proposed that disruption of desmosomes by Dsg1 might
be related to sequestration of its cytoplasmic binding partner,
plakoglobin, from E-cadherin (Norvell and Green, 1998). Here we
demonstrate that plakoglobin associated with the E-cadherin tail is
reduced in cells ectopically expressing Dsg1. This complex is
restored in Dsg1-expressing cells supertransfected with Pg.myc,
which largely restores normal desmosome morphology. The trend
toward restoration of desmosome assembly by plakoglobin in this
study extends a previous study demonstrating that the plakoglobin
binding domain on the Dsg1 tail is required for its disruptive effects
in the context of a connexin±Dsg1 chimera (Troyanovsky et al,
1994). The plakoglobin:E-cadherin complex is not affected by the
expression of ectopic nondisruptive Dsg2.myc or Dsc2.myc. When
E-cadherin was immunoprecipitated from cells expressing ectopic
Dsc1a, however, which does not disrupt desmosomes, a decrease in
plakoglobin associated with E-cadherin was also observed in certain
cases. Together, these results suggest that, although E-cadherin:-
Figure 7. Supertransfection of A431 lines
expressing Dsg1.myc with Dsc1.myc does
not lead to their incorporation into
desmosomes or rescue desmosome assembly.
A431/Dsg1 18 line was supertransfected with
plasmids encoding Dsc1a.myc (a±c) or Dsc1b.myc
(d±f) or neomycin-resistant marker (g±i) as control.
Triple-label immuno¯uorescence was performed
on mass-selected A431 cells using antibodies
against Dsc1 (a, d, g), Dsg1 (b, e, h), and
desmoplakin (c, f, i) and compared with Neo
control lines labeled for desmoplakin (j). Note that
Dsg1 and Dsc1a, Dsc1b retain their same
respective distributions in cells coexpressing these
proteins compared with cells singly expressing
these proteins. In addition, the disorganized patter
of desmoplakin staining typical for cells expressing
Dsg1 was still largely evident compared with the
more regular pattern exhibited by Neo control
lines. Scale bar: 10 mm.
Figure 8. The ratio of plakoglobin to E-cadherin is depressed in
A431 cells expressing Dsg1.myc, Dsc1a.myc. Immunoprecipitation
was performed using an antibody against E-cadherin (795) for A431
expressing myc-tagged desmosomal cadherins. Subsequently,
immunoblots were performed using an antibody against E-cadherin
(HECD-1) on the top half of the blot and an antibody against
plakoglobin (1407) on the bottom half of the blot. Note that the levels
of plakoglobin coimmunoprecipitated with E-cadherin were decreased in
Dsg1 18, Dsg1/Neo-G2, G3, and Dsc1a-L1 compared with the Neo
control line.
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plakoglobin complexes may contribute to signaling or nucleating
desmosome assembly, a modest reduction in plakoglobin associated
with E-cadherin is not suf®cient to disrupt desmosome assembly.
In summary, this work shows for the ®rst time that stable
assembly of full-length desmosomal cadherins into desmosomes of
epithelial cells is isoform dependent. Our observations suggest
furthermore that epithelial cells can tolerate wide ranges in the
levels of endogenous cadherins, whereas low levels of cadherins
expressed out of their normal cellular context can disrupt
desmosomes. Disruption is also dependent on cell-type-speci®c
factors that remain to be fully elucidated. These data highlight the
importance of a differentiation program in which the temporal and
spatial expression pattern of differentiation-speci®c desmosomal
cadherins is coordinated with that of binding partners, which
facilitate their ef®cient incorporation into desmosomes.
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